- Previous Close
0.8100 - Open
0.8100 - Bid --
- Ask --
- Day's Range
0.8100 - 0.8100 - 52 Week Range
0.8100 - 0.8100 - Volume
349 - Avg. Volume
-- - Market Cap (intraday)
-- - Beta (5Y Monthly) 3.12
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
bioAffinity Technologies, Inc. engages in developing non-invasive diagnostics to detect early-stage lung cancer and other diseases of the lung. It offers CyPath lung, a diagnostic test, for early detection of lung cancer. The company was incorporated in 2014 and is based in San Antonio, Texas.
www.bioaffinitytech.comRecent News: BIAFW
View More
Compare To: BIAFW
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: BIAFW
View MoreValuation Measures
Market Cap
--
Enterprise Value
--
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-119.41%
Return on Assets (ttm)
-69.78%
Return on Equity (ttm)
-151.52%
Revenue (ttm)
7.32M
Net Income Avi to Common (ttm)
-8.74M
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
801.31k
Total Debt/Equity (mrq)
40.20%
Levered Free Cash Flow (ttm)
-4.29M
Research Analysis: BIAFW
View MoreCompany Insights: BIAFW
BIAFW does not have Company Insights